Clinical Trial Details
— Status: Terminated
Administrative data
NCT number |
NCT04207905 |
Other study ID # |
HUM00168117 |
Secondary ID |
|
Status |
Terminated |
Phase |
|
First received |
|
Last updated |
|
Start date |
January 1, 2020 |
Est. completion date |
March 4, 2020 |
Study information
Verified date |
March 2024 |
Source |
University of Michigan |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The Centers for Medicare & Medicaid Services (CMS) approved the renewal of the Healthy
Michigan Plan (HMP) Section 1115 Demonstration Waiver on December 21, 2018, for the period
January 1, 2019-December 31, 2023. This waiver provides approval for the state to require
Medicaid expansion beneficiaries ages 19-62 to complete and report 80 hours per month of
community engagement as a condition of eligibility, among other waiver provisions, beginning
January 1, 2020. Community engagement activities include employment, education, job training,
job search activities, participation in substance use disorder (SUD) treatment, or community
service.
The State of Michigan will implement a randomized controlled trial (RCT) to evaluate the
impact of community engagement requirements on Medicaid enrollment, health insurance
coverage, self-reported health status, access to and utilization of health services,
earnings, and employment, compared to a control group of HMP enrollees exempted from the
community engagement requirement for purposes of the evaluation.
Description:
Goals of the Demonstration
As stated by the Michigan Department of Health and Human Services (MDHHS), the overarching
goals of the Healthy Michigan Plan (HMP) demonstration are to increase access to quality
health care, encourage the utilization of high-value services, promote beneficiary adoption
of healthy behaviors, and implement evidence-based practice initiatives.
The main objectives of MDHHS for HMP include:
- Improving access to healthcare for uninsured or underinsured low-income Michigan
residents;
- Improving the quality of healthcare services delivered;
- Reducing uncompensated care;
- Strengthening beneficiary engagement and personal responsibility;
- Encouraging individuals to seek preventive care, adopt healthy behaviors, and make
responsible decisions about their healthcare;
- Supporting coordinated strategies to address social determinants of health in order to
promote positive health outcomes, greater independence, and improved quality of life;
- Helping uninsured or underinsured individuals manage their health care issues;
- Encouraging quality, continuity, and appropriate medical care.
The evaluation for this demonstration is focused on examining:
- The impact of the community engagement requirement on enrollees' employment, earnings
and financial well-being; enrollment in other public support programs; health outcomes;
and health insurance status (HMP, commercial health insurance, or uninsurance);
- The extent to which new eligibility and coverage policies impact:
- Hospital uncompensated care
- Insurance coverage in the state
- Overall HMP enrollment and characteristics of HMP enrollees
- Enrollees' health care utilization
- Medicaid health service expenditures
- The impact HMP has had on enrollees' health outcomes, employment status, and financial
well-being;
- The experiences of HMP enrollees who are disenrolled regarding insurance coverage
status, access to care, and re-enrollment; and
- Medicaid program sustainability, including Medicaid expenditures.
The RCT design involves the random selection of a control group of HMP enrollees from across
the state who are expected to be subject to the community engagement requirement but who are
designated as being not subject to this requirement during the evaluation period (January 1,
2020 through December 31, 2023). This control group will be compared to an intervention group
of HMP enrollees who will be subject to the community engagement requirement. Individuals who
enroll in HMP after randomization occurs will not be eligible for inclusion in the control
group.
The random selection of the control group (22,917 HMP enrollees, representing 10% of the
individuals identified as subject to the work requirements as of November 2019) was performed
in December 2019. This sample size for the control group will enable longitudinal analysis of
key outcomes (e.g., employment, insurance coverage, self-reported health status, health
services utilization, income, and credit outcomes) over the demonstration period, with
sufficient statistical power to assess differences in these outcomes.
Data sources will include beneficiary surveys; state administrative data, including Medicaid
enrollment files, Medicaid administrative claims, specialty behavioral health administrative
claims, Michigan Care Improvement Registry immunization history, health risk assessment
tables, cost-share tables, and other Medicaid tables; state workforce data, including state
unemployment insurance program data; and public use data, including American Community
Survey, Current Population Survey, Medicaid enrollment data from Medicaid Budget and
Expenditure System (MBES), Medicaid and Medicare cost reports, Credit data, Behavioral Risk
Factor Surveillance System, Healthcare Cost & Utilization Project (HCUP) inpatient discharge
data, and program administrative cost data.